Alteration of 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes

Molecular and Cellular Biochemistry

Volumn 324, Issue 1-2, 2009, Pages 147-155

  Zhang, Ming ^a   Lv, Xiao Yan ^a   Li, Jing ^a   Xu, Zhi Gang ^a   Chen, Li ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

11 hydroxysteroid dehydrogenase type 1; Glucocorticoids receptors; Insulin signaling pathway; Type 2 diabetes mellitus

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CHOLESTEROL; GLUCOCORTICOID RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; PROTEIN KINASE B; STREPTOZOCIN; TRIACYLGLYCEROL; 11BETA HYDROXYSTEROID DEHYDROGENASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ENZYME PHOSPHORYLATION; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN TOLERANCE TEST; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; PATHOLOGY;

RATTUS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; INSULIN; MUSCLE, SKELETAL; RATS; RECEPTOR, INSULIN; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 61549099632     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9993-0     Document Type: Article

References (32)

1. Virally M, Blickle JF, Girard J et al (2007) Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives. Diabetes Metab 33:231-244. doi: 10.1016/ j.diabet.2007.07.001
2. Henness S (2007) Pharmacological interventions in the prevention of type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 14:166-169
3. Dallman MF, Akana SF, Pecoraro NC et al (2007) Glucocorticoids, the etiology of obesity and the metabolic syndrome. Curr Alzheimer Res 4:199-204. doi: 10.2174/156720507780362236
4. Tomlinson JW, Stewart PM (2007) Modulation of glucocorticoid action and the treatment of type-2 diabetes. Best Pract Res Clin Endocrinol Metab 21:607-619. doi: 10.1016/j.beem.2007.07.003
5. Stimson RH, Walker BR (2007) Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Minerva Endocrinol 32:141-159
6. Bamberger CM, Schulte HM, Chrousos GP (1996) Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17:245-261. doi: 10.1210/er.17.3.245
7. Buckingham JC (2006) Glucocorticoids: Exemplars of multi-tasking. Br J Pharmacol 147(Suppl 1):S258-S268. doi: 10.1038/sj.bjp.0706456
8. Walker BR, Andrew R (2006) Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann NY Acad Sci 1083:165-184. doi: 10.1196/annals.1367.012
9. Livingstone DE, Walker BR (2003) Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats. J Pharmacol Exp Ther 305:167-172. doi: 10.1124/ jpet.102.044842
10. Drake AJ, Livingstone DE, Andrew R et al (2005) Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology 146:913-919. doi: 10.1210/en.2004-1063
11. Bujalska IJ, Kumar S, Hewison M, Stewart PM (1999) Differentiation of adipose stromal cells: The roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 140:3188-3196. doi: 10.1210/en.140.7.3188
12. Handoko K, Yang K, Strutt B et al (2000) Insulin attenuates the stimulatory effects of tumor necrosis factor alpha on 11beta-hydroxysteroid dehydrogenase 1 in human adipose stromal cells. J Steroid Biochem Mol Biol 72:163-168. doi: 10.1016/S0960-0760(00)00029-7
13. Karlsson HK, Zierath JR (2007) Insulin signaling and glucose transport in insulin resistant human skeletal muscle. Cell Biochem Biophys 48:103-113. doi: 10.1007/s12013-007-0030-9
14. Whorwood CB, Donovan SJ, Wood PJ et al (2001) Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: A key role in the pathogenesis of insulin resistance? J Clin Endocrinol Metab 86:2296-2308. doi: 10.1210/jc.86.5.2296
15. Whorwood CB, Donovan SJ, Flanagan D et al (2002) Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 51:1066-1075. doi: 10.2337/diabetes.51.4.1066
16. Seckl JR, Morton NM, Chapman KE et al (2004) Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 59:359-393. doi: 10.1210/rp.59.1.359
17. Alberts P, Nilsson C, Selen G et al (2003) Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144:4755-4762. doi: 10.1210/en.2003-0344
18. Hermanowski-Vosatka A, Balkovec JM et al (2005) 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202:517-527. doi: 10.1084/jem.20050119
19. Andrews RC, Rooyackers O, Walker BR (2003) Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 88:285-291. doi: 10.1210/jc.2002-021194
20. Sandeep TC, Andrew R, Homer NZ et al (2005) Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54:872-879. doi: 10.2337/diabetes.54.3.872
21. Okret S, Poellinger L, Dong Y et al (1986) Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone. Proc Natl Acad Sci USA 83:5899-5903. doi: 10.1073/pnas.83.16.5899
22. Freeman AI, Munn HL, Lyons V et al (2004) Glucocorticoid down-regulation of rat glucocorticoid receptor does not involve differential promoter regulation. J Endocrinol 183:365-374. doi: 10.1677/joe.1.05773
23. Burnstein KL, Bellingham DL, Jewell CM et al (1991) Autoregulation of glucocorticoid receptor gene expression. Steroids 56:52-58. doi: 10.1016/ 0039-128X(91)90124-E
24. Burnstein KL, Jewell CM, Sar M et al (1994) Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms. Mol Endocrinol 8:1764-1773. doi: 10.1210/ me.8.12.1764
25. Silva CM, Powell-Oliver FE, Jewell CM et al (1994) Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 59:436-442. doi: 10.1016/0039-128X(94)90013-2
26. Vig E, Barrett TJ, Vedeckis WV (1994) Coordinate regulation of glucocorticoid receptor and c-jun mRNA levels: Evidence for cross-talk between two signaling pathways' at the transcriptional level. Mol Endocrinol 8:1336-1346. doi: 10.1210/me.8.10.1336
27. Nobukuni Y, Smith CL, Hager GL et al (1995) Characterization of the human glucocorticoid receptor promoter. Biochemistry 34:8207-8214. doi: 10.1021/bi00025a028
28. Burnstein KL, Jewell CM, Cidlowski JA (1990) Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation. J Biol Chem 265:7284-7291
29. Zong J, Ashraf J, Thompson EB (1990) The promoter and first, untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor element sites. Mol Cell Biol 10:5580-5585
30. Vicker N, Su X, Ganeshapillai D et al (2007) Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. J Steroid Biochem Mol Biol 104:123-129. doi: 10.1016/j.jsbmb.2007.03.023
31. Tremblay F, Lavigne C, Jacques H et al (2003) Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats. Diabetes 52:29-37. doi: 10.2337/diabetes.52.1.29
32. Tremblay F, Lavigne C, Jacques H et al (2001) Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 50:1901-1910. doi: 10.2337/diabetes.50.8.1901